Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
36.96
-0.90 (-2.38%)
Aug 14, 2025, 11:35 AM - Market open
Collegium Pharmaceutical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 36.27 | 69.19 | 48.16 | -25 | 71.52 | 26.75 | Upgrade
|
| Depreciation & Amortization | 211.43 | 169.16 | 149.26 | 134.15 | 68.92 | 61.55 | Upgrade
|
| Other Amortization | 5.35 | 6.02 | 8.64 | 8.29 | 3.41 | 8.97 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 4.79 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.48 | -2.03 | -1.24 | - | - | - | Upgrade
|
| Stock-Based Compensation | 37.26 | 32.4 | 27.14 | 22.87 | 24.26 | 21.91 | Upgrade
|
| Other Operating Activities | -16.64 | -14.78 | 21.07 | -8.15 | -78.02 | 0.06 | Upgrade
|
| Change in Accounts Receivable | 15.43 | -4.41 | 3.59 | -21.78 | -22.52 | -10.37 | Upgrade
|
| Change in Inventory | 6.87 | 13.93 | 14.17 | 48.27 | -2.3 | -8.27 | Upgrade
|
| Change in Accounts Payable | 1.82 | -11.28 | 5.06 | -0.71 | -5.83 | 3.77 | Upgrade
|
| Change in Other Net Operating Assets | -92.83 | -53.21 | -1.09 | -38.5 | 44.13 | -10.43 | Upgrade
|
| Operating Cash Flow | 203.48 | 204.98 | 274.75 | 124.23 | 103.56 | 93.94 | Upgrade
|
| Operating Cash Flow Growth | -26.46% | -25.39% | 121.16% | 19.96% | 10.23% | 238.13% | Upgrade
|
| Capital Expenditures | -1.68 | -1.65 | -0.46 | -1.62 | -1.94 | -5.55 | Upgrade
|
| Cash Acquisitions | -267.54 | -267.54 | - | -572.07 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -368.23 | Upgrade
|
| Investment in Securities | -4.11 | -18.57 | -70.35 | - | - | - | Upgrade
|
| Investing Cash Flow | -273.32 | -287.76 | -70.81 | -573.69 | -1.94 | -373.77 | Upgrade
|
| Long-Term Debt Issued | - | 325 | 241.5 | 517.68 | - | 338.32 | Upgrade
|
| Total Debt Issued | 325 | 325 | 241.5 | 517.68 | - | 338.32 | Upgrade
|
| Long-Term Debt Repaid | - | -305.66 | -301.14 | -75 | -50 | -49 | Upgrade
|
| Net Debt Issued (Repaid) | 111.94 | 19.34 | -59.64 | 442.68 | -50 | 289.32 | Upgrade
|
| Issuance of Common Stock | 3.16 | 11.07 | 9.1 | 12.15 | 12.71 | 7.34 | Upgrade
|
| Repurchase of Common Stock | -61.57 | -79.2 | -83.36 | -18.11 | -52.01 | -2.26 | Upgrade
|
| Other Financing Activities | -19.38 | -11.83 | -6.28 | - | - | -7.93 | Upgrade
|
| Financing Cash Flow | 34.15 | -60.6 | -140.18 | 436.72 | -89.3 | 286.47 | Upgrade
|
| Net Cash Flow | -35.69 | -143.38 | 63.76 | -12.74 | 12.31 | 6.64 | Upgrade
|
| Free Cash Flow | 201.81 | 203.33 | 274.29 | 122.61 | 101.61 | 88.4 | Upgrade
|
| Free Cash Flow Growth | -26.78% | -25.87% | 123.71% | 20.66% | 14.95% | 314.13% | Upgrade
|
| Free Cash Flow Margin | 28.54% | 32.20% | 48.39% | 26.43% | 36.70% | 28.51% | Upgrade
|
| Free Cash Flow Per Share | 5.07 | 5.03 | 6.56 | 3.62 | 2.48 | 2.52 | Upgrade
|
| Cash Interest Paid | 68.43 | 62.43 | 73.26 | 52.53 | 17.61 | 18.97 | Upgrade
|
| Cash Income Tax Paid | 48.48 | 52.09 | 24.21 | 10.4 | 3.01 | 0.48 | Upgrade
|
| Levered Free Cash Flow | 336.48 | 362.08 | 274.32 | 70.53 | 109.21 | -288.37 | Upgrade
|
| Unlevered Free Cash Flow | 382.57 | 402.3 | 317.77 | 101.75 | 118.93 | -279.29 | Upgrade
|
| Change in Working Capital | -68.71 | -54.98 | 21.73 | -12.71 | 13.49 | -25.3 | Upgrade
|
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.